Pillstats
Rx only · Capsule · Oral

Bismuth Subcitrate Potassium, Metronidazole And Tetracycline Hydrochloride

Brands: Pylera · Bismuth Subcitrate Potassium + Metronidazole + Tetracycline Hydrochloride

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)10395
US makers2 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.807$1.61$2.42$3.23Dec 2025Apr 2026Jul 2026
$2.412
Latest avg · Jul 22, 2026
-14%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.9K3.8K5.7K7.6K2025 Q12025 Q22025 Q32025 Q42026 Q1
5.6K
Rx · 2026 Q1
711K
Units dispensed
+7%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
H2-Pharma, LLCunknown3SUPPLYING
Par Health USA, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.